Nucleoside Metabolic Inhibitor [EPC]

Nucleoside Metabolic Inhibitor [EPC] was reported 274072 times

These side effects are most commonly reported by patients taking drugs of the Nucleoside Metabolic Inhibitor [EPC] class:

# Drug class Count
0 DIARRHOEA 24111
1 DEATH 19709
2 NAUSEA 17607
3 FEBRILE NEUTROPENIA 15661
4 OFF LABEL USE 15496
5 NEUTROPENIA 14507
6 DISEASE PROGRESSION 14282
7 VOMITING 13272
8 FATIGUE 12881
9 PYREXIA 12114
10 THROMBOCYTOPENIA 10283
11 DRUG INEFFECTIVE 9506
12 ANAEMIA 8717
13 ASTHENIA 7997
14 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7563
15 PNEUMONIA 7514
16 MALIGNANT NEOPLASM PROGRESSION 7491
17 SEPSIS 7285
18 NEUROPATHY PERIPHERAL 7173
19 MYELOSUPPRESSION 7058
20 DECREASED APPETITE 6980
21 DYSPNOEA 6558
22 ABDOMINAL PAIN 5783
23 MUCOSAL INFLAMMATION 5782
24 PLATELET COUNT DECREASED 5761
25 WHITE BLOOD CELL COUNT DECREASED 5339
26 DEHYDRATION 5300
27 RASH 5201
28 PANCYTOPENIA 4977
29 INFECTION 4895
30 STOMATITIS 4639
31 PAIN 4412
32 ACUTE MYELOID LEUKAEMIA 4251
33 CONSTIPATION 4242
34 HYPOTENSION 4195
35 PRODUCT USE IN UNAPPROVED INDICATION 3979
36 WEIGHT DECREASED 3930
37 NEUTROPHIL COUNT DECREASED 3921
38 SEPTIC SHOCK 3883
39 HEADACHE 3825
40 MALAISE 3821
41 LEUKOPENIA 3813
42 GENERAL PHYSICAL HEALTH DETERIORATION 3676
43 ACUTE KIDNEY INJURY 3674
44 DIZZINESS 3472
45 HAEMOGLOBIN DECREASED 3237
46 HYPERTENSION 3029
47 TOXICITY TO VARIOUS AGENTS 3003
48 PULMONARY EMBOLISM 2999
49 RESPIRATORY FAILURE 2981
50 ERYTHEMA 2973
51 BONE MARROW FAILURE 2972
52 NEOPLASM PROGRESSION 2952
53 PLEURAL EFFUSION 2927
54 HYPOKALAEMIA 2921
55 PARAESTHESIA 2785
56 PAIN IN EXTREMITY 2758
57 RENAL FAILURE 2744
58 COUGH 2695
59 METASTASES TO LIVER 2690
60 CHEST PAIN 2533
61 NEUROTOXICITY 2437
62 CHILLS 2394
63 BACK PAIN 2392
64 PRURITUS 2358
65 ABDOMINAL PAIN UPPER 2265
66 ALOPECIA 2261
67 FALL 2247
68 CONDITION AGGRAVATED 2243
69 COLITIS 2148
70 ALANINE AMINOTRANSFERASE INCREASED 2118
71 URINARY TRACT INFECTION 2110
72 INTERSTITIAL LUNG DISEASE 2096
73 HYPOAESTHESIA 2070
74 TACHYCARDIA 2005
75 MYELODYSPLASTIC SYNDROME 2002
76 ASCITES 1953
77 DYSPHAGIA 1950
78 HAEMATOTOXICITY 1948
79 CARDIAC FAILURE 1923
80 ARTHRALGIA 1909
81 OEDEMA PERIPHERAL 1908
82 ASPARTATE AMINOTRANSFERASE INCREASED 1877
83 EPISTAXIS 1859
84 ATRIAL FIBRILLATION 1855
85 RENAL IMPAIRMENT 1847
86 BLOOD BILIRUBIN INCREASED 1828
87 DRUG INTERACTION 1823
88 CONFUSIONAL STATE 1793
89 DEEP VEIN THROMBOSIS 1760
90 CYTOPENIA 1758
91 DRY SKIN 1719
92 BLOOD CREATININE INCREASED 1704
93 SKIN EXFOLIATION 1684
94 HYPERSENSITIVITY 1677
95 CARDIAC ARREST 1662
96 COVID-19 1662
97 HAEMORRHAGE 1630
98 GASTROINTESTINAL HAEMORRHAGE 1623
99 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1609
100 HYPONATRAEMIA 1606
101 THERAPY PARTIAL RESPONDER 1576
102 METASTASES TO BONE 1565
103 HEPATIC FUNCTION ABNORMAL 1552
104 METASTASES TO LUNG 1531
105 DRUG INTOLERANCE 1530
106 INTENTIONAL PRODUCT USE ISSUE 1473
107 PRODUCT USE ISSUE 1466
108 INTESTINAL OBSTRUCTION 1445
109 GASTROINTESTINAL DISORDER 1429
110 HYPERBILIRUBINAEMIA 1423
111 ABDOMINAL DISTENSION 1407
112 TUMOUR LYSIS SYNDROME 1402
113 GAIT DISTURBANCE 1387
114 BREAST CANCER METASTATIC 1353
115 SYNCOPE 1346
116 THROMBOSIS 1316
117 HEPATIC FAILURE 1315
118 SKIN TOXICITY 1315
119 NEUTROPENIC SEPSIS 1309
120 PNEUMONITIS 1305
121 HYPOXIA 1302
122 CELLULITIS 1280
123 METASTASES TO CENTRAL NERVOUS SYSTEM 1264
124 BACTERAEMIA 1247
125 CEREBROVASCULAR ACCIDENT 1238
126 MUSCULAR WEAKNESS 1238
127 DISEASE RECURRENCE 1237
128 CARDIOTOXICITY 1229
129 INSOMNIA 1215
130 RENAL FAILURE ACUTE 1213
131 PERIPHERAL SWELLING 1209
132 HOSPITALISATION 1204
133 MUSCLE SPASMS 1201
134 SEIZURE 1198
135 MYOCARDIAL INFARCTION 1189
136 HEPATOTOXICITY 1183
137 ACUTE MYELOID LEUKAEMIA RECURRENT 1178
138 ARTERIOSPASM CORONARY 1172
139 VENOOCCLUSIVE LIVER DISEASE 1168
140 PULMONARY OEDEMA 1162
141 SOMNOLENCE 1152
142 BREAST CANCER 1143
143 DISSEMINATED INTRAVASCULAR COAGULATION 1137
144 ANXIETY 1133
145 POLYNEUROPATHY 1126
146 BACTERIAL INFECTION 1124
147 FUNGAL INFECTION 1123
148 INFUSION RELATED REACTION 1104
149 LOSS OF CONSCIOUSNESS 1084
150 THERAPY INTERRUPTED 1080
151 BRONCHOPULMONARY ASPERGILLOSIS 1077
152 HYPERGLYCAEMIA 1077
153 GASTROINTESTINAL TOXICITY 1075
154 ENTERITIS 1066
155 SKIN DISCOLOURATION 1063
156 ABDOMINAL DISCOMFORT 1061
157 MYALGIA 1058
158 THERAPY NON-RESPONDER 1054
159 FEBRILE BONE MARROW APLASIA 1053
160 LYMPHADENOPATHY 1043
161 C-REACTIVE PROTEIN INCREASED 1036
162 TREATMENT FAILURE 1036
163 EJECTION FRACTION DECREASED 1021
164 STAPHYLOCOCCAL INFECTION 1013
165 ACUTE RESPIRATORY DISTRESS SYNDROME 1004
166 ENCEPHALOPATHY 1000
167 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 993
168 OEDEMA 990
169 BLOOD PRESSURE INCREASED 986
170 BLOOD LACTATE DEHYDROGENASE INCREASED 984
171 NO ADVERSE EVENT 975
172 HYPOMAGNESAEMIA 969
173 DYSGEUSIA 967
174 DYSPEPSIA 959
175 TREMOR 958
176 MULTI-ORGAN FAILURE 946
177 PROTEINURIA 940
178 AGRANULOCYTOSIS 936
179 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 929
180 RESPIRATORY DISTRESS 927
181 PERICARDIAL EFFUSION 922
182 ILEUS 912
183 CEREBRAL HAEMORRHAGE 911
184 BONE PAIN 905
185 BLISTER 903
186 LIVER DISORDER 895
187 HEPATIC ENZYME INCREASED 894
188 JAUNDICE 888
189 RED BLOOD CELL COUNT DECREASED 888
190 WEIGHT INCREASED 887
191 CHEST DISCOMFORT 885
192 HYPERHIDROSIS 884
193 CYTOKINE RELEASE SYNDROME 867
194 DERMATITIS ACNEIFORM 865
195 CLOSTRIDIUM DIFFICILE COLITIS 856
196 RECTAL HAEMORRHAGE 855
197 DRUG RESISTANCE 852
198 ENTEROCOLITIS 852
199 HYPOPHAGIA 844
200 BLOOD ALKALINE PHOSPHATASE INCREASED 841
201 PERIPHERAL SENSORY NEUROPATHY 841
202 DEPRESSION 840
203 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 838
204 DRUG HYPERSENSITIVITY 833
205 HYPOALBUMINAEMIA 831
206 BLOOD PRESSURE DECREASED 829
207 TRANSAMINASES INCREASED 828
208 NEOPLASM MALIGNANT 825
209 DRUG-INDUCED LIVER INJURY 815
210 DEVICE RELATED INFECTION 813
211 DYSARTHRIA 802
212 LETHARGY 801
213 PANCREATITIS 795
214 LUNG DISORDER 789
215 SKIN FISSURES 788
216 OROPHARYNGEAL PAIN 781
217 SECOND PRIMARY MALIGNANCY 781
218 CARDIO-RESPIRATORY ARREST 780
219 METASTASES TO LYMPH NODES 777
220 NASOPHARYNGITIS 771
221 WHITE BLOOD CELL COUNT INCREASED 771
222 FEELING ABNORMAL 767
223 CARDIOMYOPATHY 755
224 BLOOD POTASSIUM DECREASED 752
225 OSTEONECROSIS 743
226 HEART RATE INCREASED 742
227 OXYGEN SATURATION DECREASED 740
228 HYPOCALCAEMIA 738
229 MOUTH ULCERATION 738
230 HAEMATURIA 734
231 COLORECTAL CANCER METASTATIC 733
232 ILL-DEFINED DISORDER 726
233 GAMMA-GLUTAMYLTRANSFERASE INCREASED 725
234 THERAPY CESSATION 723
235 CHOLESTASIS 710
236 NEUTROPENIC COLITIS 708
237 ACUTE MYOCARDIAL INFARCTION 702
238 HAEMATOCHEZIA 702
239 FLUSHING 701
240 ASPERGILLUS INFECTION 695
241 OSTEONECROSIS OF JAW 694
242 PNEUMONIA FUNGAL 688
243 CARDIAC DISORDER 685
244 VISION BLURRED 685
245 PALPITATIONS 683
246 INTESTINAL PERFORATION 680
247 HERPES ZOSTER 676
248 LEUKOCYTOSIS 675
249 PARONYCHIA 672
250 CANDIDA INFECTION 669
251 DYSPHONIA 668
252 ELECTROLYTE IMBALANCE 666
253 LYMPHOPENIA 665
254 INFLAMMATION 663
255 ARRHYTHMIA 661
256 LEUKOENCEPHALOPATHY 661
257 SMALL INTESTINAL OBSTRUCTION 660
258 MENTAL STATUS CHANGES 658
259 CONVULSION 657
260 CARDIAC FAILURE CONGESTIVE 655
261 ORAL PAIN 654
262 DRY MOUTH 653
263 SKIN DISORDER 651
264 BURNING SENSATION 647
265 LIVER INJURY 643
266 HAEMATEMESIS 642
267 ANAPHYLACTIC REACTION 634
268 DYSURIA 632
269 GASTROOESOPHAGEAL REFLUX DISEASE 631
270 METABOLIC ACIDOSIS 627
271 METASTASIS 624
272 RASH MACULO-PAPULAR 622
273 BLOOD GLUCOSE INCREASED 618
274 GRAFT VERSUS HOST DISEASE 618
275 URTICARIA 618
276 CONTUSION 612
277 CYTOMEGALOVIRUS INFECTION 612
278 BALANCE DISORDER 611
279 FULL BLOOD COUNT DECREASED 607
280 COAGULOPATHY 600
281 SKIN LESION 599
282 VISUAL IMPAIRMENT 599
283 CEREBRAL INFARCTION 594
284 ACUTE RESPIRATORY FAILURE 592
285 DEPRESSED LEVEL OF CONSCIOUSNESS 591
286 SHOCK 587
287 SWELLING 586
288 ELECTROCARDIOGRAM QT PROLONGED 582
289 ANGINA PECTORIS 581
290 DIFFUSE LARGE B-CELL LYMPHOMA 577
291 PERITONITIS 577
292 COMA 576
293 DYSPNOEA EXERTIONAL 576
294 RASH ERYTHEMATOUS 574
295 MEMORY IMPAIRMENT 572
296 NERVOUS SYSTEM DISORDER 572
297 OESOPHAGITIS 567
298 PRODUCT DOSE OMISSION ISSUE 567
299 SINUSITIS 564
300 LUNG INFILTRATION 563
301 HYPERKALAEMIA 559
302 LEFT VENTRICULAR DYSFUNCTION 557
303 BRADYCARDIA 552
304 SPLENOMEGALY 549
305 BLOOD CULTURE POSITIVE 547
306 VENTRICULAR FIBRILLATION 544
307 PANCREATITIS ACUTE 540
308 URINARY RETENTION 536
309 HYPERTRIGLYCERIDAEMIA 534
310 APHASIA 525
311 VIRAL INFECTION 525
312 GASTROINTESTINAL PERFORATION 524
313 ATELECTASIS 521
314 CLOSTRIDIUM DIFFICILE INFECTION 521
315 PULMONARY MASS 519
316 ENTEROCOCCAL INFECTION 518
317 ADVERSE DRUG REACTION 517
318 RHINORRHOEA 517
319 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 515
320 LUNG INFECTION 515
321 SPEECH DISORDER 515
322 FLATULENCE 514
323 NEPHROPATHY TOXIC 513
324 ADVERSE EVENT 512
325 THERAPEUTIC RESPONSE DECREASED 512
326 BODY TEMPERATURE INCREASED 510
327 PNEUMONIA ASPIRATION 510
328 COLON CANCER 509
329 GASTRITIS 506
330 HEPATIC CYTOLYSIS 506
331 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 505
332 EMBOLISM 505
333 HOSPICE CARE 504
334 HAEMATOCRIT DECREASED 503
335 UNEVALUABLE EVENT 503
336 UPPER RESPIRATORY TRACT INFECTION 500
337 IMPAIRED HEALING 498
338 LARGE INTESTINE PERFORATION 497
339 INFLUENZA 495
340 DERMATITIS 492
341 PNEUMOCYSTIS JIROVECII PNEUMONIA 492
342 DISORIENTATION 491
343 MELAENA 491
344 CARDIOGENIC SHOCK 490
345 DELIRIUM 485
346 HEPATIC STEATOSIS 484
347 ILLNESS 478
348 HAEMOPTYSIS 477
349 TRANSFUSION 477
350 PSEUDOMONAS INFECTION 476
351 MUSCULOSKELETAL PAIN 474
352 ESCHERICHIA INFECTION 470
353 DRUG TOXICITY 468
354 BLOOD UREA INCREASED 466
355 SINUS TACHYCARDIA 465
356 HEPATITIS 463
357 EPILEPSY 461
358 MALNUTRITION 459
359 DIABETES MELLITUS 457
360 PULMONARY HAEMORRHAGE 456
361 PNEUMOTHORAX 453
362 HEMIPARESIS 451
363 PNEUMATOSIS INTESTINALIS 451
364 SKIN ULCER 451
365 TACHYPNOEA 450
366 ACUTE CORONARY SYNDROME 449
367 CIRCULATORY COLLAPSE 449
368 LIVER FUNCTION TEST ABNORMAL 449
369 BLOOD ALBUMIN DECREASED 446
370 RENAL DISORDER 445
371 LYMPHOCYTE COUNT DECREASED 443
372 LACRIMATION INCREASED 441
373 HICCUPS 439
374 HYPERAMMONAEMIA 439
375 HEPATOCELLULAR INJURY 438
376 THROMBOTIC MICROANGIOPATHY 438
377 ALTERED STATE OF CONSCIOUSNESS 433
378 HYPOGLYCAEMIA 433
379 RASH PRURITIC 433
380 ANOREXIA 431
381 NO THERAPEUTIC RESPONSE 431
382 RESPIRATORY DISORDER 431
383 ACUTE GRAFT VERSUS HOST DISEASE 429
384 SKIN REACTION 429
385 STAPHYLOCOCCAL SEPSIS 428
386 OVERDOSE 426
387 PAIN IN JAW 426
388 APLASIA 424
389 SWELLING FACE 424
390 PRODUCTIVE COUGH 423
391 FEELING HOT 422
392 PULMONARY FIBROSIS 422
393 PSEUDOMONAL SEPSIS 420
394 BRONCHITIS 419
395 SUBDURAL HAEMATOMA 418
396 TUMOUR MARKER INCREASED 416
397 KLEBSIELLA INFECTION 415
398 COGNITIVE DISORDER 413
399 UNRESPONSIVE TO STIMULI 413
400 ESCHERICHIA BACTERAEMIA 412
401 METASTASES TO PERITONEUM 411
402 RESPIRATORY TRACT INFECTION 411
403 NEOPLASM RECURRENCE 410
404 CHOLANGITIS 409
405 HAEMORRHAGE INTRACRANIAL 408
406 PALLOR 407
407 PERICARDITIS 407
408 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 405
409 BRAIN OEDEMA 404
410 HYPOTHYROIDISM 404
411 MYOCARDIAL ISCHAEMIA 402
412 STAPHYLOCOCCAL BACTERAEMIA 401
413 BLOOD SODIUM DECREASED 400
414 HEPATIC LESION 399
415 TRANSIENT ISCHAEMIC ATTACK 398
416 VENOOCCLUSIVE DISEASE 398
417 CYSTITIS HAEMORRHAGIC 393
418 NEOPLASM 393
419 ISCHAEMIC STROKE 392
420 NAIL DISORDER 392
421 AGITATION 391
422 VENTRICULAR TACHYCARDIA 391
423 CHOLELITHIASIS 390
424 HOT FLUSH 390
425 HYDRONEPHROSIS 389
426 SUDDEN DEATH 387
427 VERTIGO 386
428 CYSTITIS 385
429 NECK PAIN 385
430 PORTAL HYPERTENSION 385
431 BACTERIAL SEPSIS 384
432 GRANULOCYTE COUNT DECREASED 381
433 CONJUNCTIVITIS 376
434 TEMPERATURE INTOLERANCE 375
435 BLINDNESS 372
436 LYMPHOMA 370
437 PROCTALGIA 370
438 MYOCARDITIS 368
439 ESCHERICHIA SEPSIS 367
440 INTESTINAL ISCHAEMIA 367
441 GINGIVAL BLEEDING 366
442 HAEMORRHOIDS 365
443 ORAL HERPES 365
444 DISCOMFORT 364
445 CHOLECYSTITIS 363
446 CYTOMEGALOVIRUS INFECTION REACTIVATION 363
447 POLLAKIURIA 362
448 HYPERTRANSAMINASAEMIA 360
449 HALLUCINATION 358
450 ABSCESS 357
451 DIVERTICULITIS 357
452 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 356
453 LEUKAEMIA RECURRENT 355
454 CARCINOEMBRYONIC ANTIGEN INCREASED 354
455 HYPOPHOSPHATAEMIA 354
456 MYELOPATHY 353
457 URINARY INCONTINENCE 353
458 ATAXIA 352
459 INTERNATIONAL NORMALISED RATIO INCREASED 351
460 GASTROENTERITIS 350
461 ORAL CANDIDIASIS 344
462 HEPATOMEGALY 343
463 OSTEOMYELITIS 343
464 UPPER GASTROINTESTINAL HAEMORRHAGE 343
465 JOINT SWELLING 342
466 LEUKAEMIA 341
467 CYTOMEGALOVIRUS VIRAEMIA 340
468 NEURALGIA 339
469 VENOUS THROMBOSIS 339
470 FEEDING DISORDER 338
471 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 337
472 HERPES SIMPLEX 336
473 PULMONARY TOXICITY 336
474 BONE DISORDER 335
475 IMMUNODEFICIENCY 335
476 TASTE DISORDER 333
477 PETECHIAE 332
478 DRY EYE 331
479 LOWER RESPIRATORY TRACT INFECTION 331
480 INCORRECT DOSE ADMINISTERED 328
481 CACHEXIA 327
482 DIPLOPIA 327
483 HAEMOGLOBIN ABNORMAL 327
484 MATERNAL EXPOSURE DURING PREGNANCY 327
485 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 325
486 HYPOGAMMAGLOBULINAEMIA 324
487 STRESS CARDIOMYOPATHY 323
488 HYPOVOLAEMIC SHOCK 321
489 PNEUMONIA BACTERIAL 321
490 DRUG ERUPTION 320
491 RASH PUSTULAR 318
492 SURGERY 315
493 FLUID RETENTION 314
494 LACTIC ACIDOSIS 314
495 MUSCULOSKELETAL STIFFNESS 314
496 TOXIC EPIDERMAL NECROLYSIS 314
497 HAEMOLYTIC ANAEMIA 312
498 ORGANISING PNEUMONIA 312
499 SLEEP DISORDER 312
500 ABDOMINAL PAIN LOWER 311
501 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 310
502 MUCORMYCOSIS 310
503 GENERALISED OEDEMA 309
504 MOBILITY DECREASED 309
505 CHRONIC GRAFT VERSUS HOST DISEASE 306
506 EATING DISORDER 306
507 ILEUS PARALYTIC 302
508 TOXIC SKIN ERUPTION 302
509 AMNESIA 300
510 LARYNGOSPASM 300
511 ACNE 298
512 ANAPHYLACTIC SHOCK 296
513 FEELING COLD 296
514 METASTATIC NEOPLASM 296
515 ACIDOSIS 294
516 LIVER FUNCTION TEST INCREASED 294
517 CARDIAC FAILURE ACUTE 291
518 SYSTEMIC CANDIDA 290
519 INFLUENZA LIKE ILLNESS 289
520 LIVER ABSCESS 289
521 ACUTE LYMPHOCYTIC LEUKAEMIA 286
522 FISTULA 286
523 STEVENS-JOHNSON SYNDROME 286
524 HYPERAMMONAEMIC ENCEPHALOPATHY 285
525 LABORATORY TEST ABNORMAL 285
526 ECZEMA 283
527 DEAFNESS 282
528 METASTASES TO SPINE 282
529 CHRONIC KIDNEY DISEASE 281
530 HEPATIC ENCEPHALOPATHY 281
531 RECURRENT CANCER 281
532 GASTRIC ULCER 280
533 NIGHT SWEATS 280
534 SUPRAVENTRICULAR TACHYCARDIA 279
535 GASTROINTESTINAL INFLAMMATION 278
536 INJECTION SITE PAIN 278
537 HUMAN HERPESVIRUS 6 INFECTION 277
538 SECONDARY IMMUNODEFICIENCY 277
539 WHITE BLOOD CELL COUNT ABNORMAL 277
540 HYPERCALCAEMIA 276
541 GRANULOCYTOPENIA 275
542 HEPATIC CIRRHOSIS 275
543 DIARRHOEA HAEMORRHAGIC 274
544 ULCER 274
545 UNDERDOSE 274
546 CATARACT 273
547 RHINOVIRUS INFECTION 273
548 SUBARACHNOID HAEMORRHAGE 273
549 BLOOD MAGNESIUM DECREASED 272
550 RASH MACULAR 272
551 COLON CANCER METASTATIC 271
552 FOETAL EXPOSURE DURING PREGNANCY 271
553 HAEMATOMA 271
554 OESOPHAGEAL CANDIDIASIS 270
555 ENCEPHALITIS 269
556 PARAINFLUENZAE VIRUS INFECTION 269
557 BLOOD CALCIUM DECREASED 268
558 BRONCHOSPASM 268
559 COLORECTAL CANCER 268
560 NEPHROLITHIASIS 268
561 DEPRESSED MOOD 266
562 ORTHOSTATIC HYPOTENSION 266
563 ADRENAL INSUFFICIENCY 263
564 BLAST CELL COUNT INCREASED 263
565 ODYNOPHAGIA 262
566 GASTROINTESTINAL NECROSIS 261
567 PULMONARY ALVEOLAR HAEMORRHAGE 261
568 PULMONARY HYPERTENSION 261
569 GAIT INABILITY 260
570 MEDICATION ERROR 260
571 PERFORMANCE STATUS DECREASED 260
572 ARTHRITIS 259
573 AZOTAEMIA 259
574 CENTRAL NERVOUS SYSTEM LESION 259
575 EPSTEIN-BARR VIRUS INFECTION 259
576 HAEMODYNAMIC INSTABILITY 259
577 GUILLAIN-BARRE SYNDROME 258
578 DRUG EXPOSURE DURING PREGNANCY 257
579 LIP SWELLING 257
580 FAECES DISCOLOURED 256
581 RETCHING 256
582 SHOCK HAEMORRHAGIC 256
583 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 256
584 THROAT TIGHTNESS 256
585 ANGIOEDEMA 255
586 COVID-19 PNEUMONIA 255
587 HYPOVOLAEMIA 254
588 NEPHROTIC SYNDROME 253
589 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 252
590 ENTEROBACTER INFECTION 252
591 RHABDOMYOLYSIS 252
592 ACUTE PROMYELOCYTIC LEUKAEMIA 251
593 IMMUNOSUPPRESSION 251
594 MUSCULOSKELETAL CHEST PAIN 251
595 MITRAL VALVE INCOMPETENCE 250
596 APPENDICITIS 249
597 PLATELET COUNT ABNORMAL 249
598 BLOOD COUNT ABNORMAL 248
599 HYPERTHERMIA 248
600 SKIN INFECTION 248
601 TOOTHACHE 247
602 DRUG DOSE OMISSION 246
603 SKIN HYPERPIGMENTATION 246
604 GRAFT VERSUS HOST DISEASE IN SKIN 245
605 FACE OEDEMA 244
606 MASS 244
607 HEART RATE DECREASED 243
608 NEUTROPHIL COUNT ABNORMAL 243
609 POST PROCEDURAL COMPLICATION 243
610 PRESYNCOPE 243
611 VISUAL ACUITY REDUCED 243
612 ACUTE HEPATIC FAILURE 242
613 BLOOD TEST ABNORMAL 242
614 EYE PAIN 242
615 HYPERTENSIVE CRISIS 240
616 NECROTISING FASCIITIS 239
617 BREAST CANCER RECURRENT 238
618 VASCULAR DEVICE INFECTION 238
619 BLOOD DISORDER 237
620 LIPASE INCREASED 237
621 WHEEZING 237
622 HYPERAESTHESIA 236
623 PLATELET COUNT INCREASED 236
624 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 235
625 TINNITUS 235
626 TROPONIN INCREASED 234
627 EYE IRRITATION 233
628 FLUID OVERLOAD 233
629 LOCALISED INFECTION 232
630 ADENOCARCINOMA OF COLON 230
631 MYOSITIS 229
632 PROCTITIS 229
633 SENSORY DISTURBANCE 229
634 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 228
635 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 228
636 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 227
637 FREQUENT BOWEL MOVEMENTS 227
638 FUNGAEMIA 227
639 PIGMENTATION DISORDER 227
640 APLASTIC ANAEMIA 226
641 CYTOMEGALOVIRUS CHORIORETINITIS 226
642 PERIPHERAL COLDNESS 226
643 PREMATURE BABY 226
644 ACUTE PULMONARY OEDEMA 225
645 METASTASES TO MENINGES 225
646 NECROSIS 225
647 HAEMOLYSIS 224
648 PANCREATIC CARCINOMA 224
649 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 224
650 SWOLLEN TONGUE 224
651 BLOOD CREATINE PHOSPHOKINASE INCREASED 223
652 DIABETIC KETOACIDOSIS 223
653 DUODENAL ULCER 221
654 GASTRIC CANCER 221
655 PATHOGEN RESISTANCE 220
656 TOOTH EXTRACTION 220
657 EMOTIONAL DISTRESS 219
658 GENERALISED TONIC-CLONIC SEIZURE 219
659 HAEMODIALYSIS 219
660 COLITIS ISCHAEMIC 218
661 RENAL TUBULAR NECROSIS 218
662 TUBULOINTERSTITIAL NEPHRITIS 218
663 ANURIA 217
664 PURPURA 217
665 SKIN BURNING SENSATION 217
666 STEM CELL TRANSPLANT 217
667 THROAT IRRITATION 217
668 TREATMENT NONCOMPLIANCE 217
669 ORAL DISORDER 216
670 STRESS 216
671 HEPATITIS B 214
672 METASTASES TO SKIN 214
673 NEUTROPHIL COUNT INCREASED 214
674 WOUND 214
675 BRAIN NEOPLASM 213
676 CAPILLARY LEAK SYNDROME 213
677 CHROMATURIA 213
678 RESTLESSNESS 212
679 SUBILEUS 212
680 ADENOVIRUS INFECTION 211
681 LYMPHOEDEMA 211
682 MOUTH HAEMORRHAGE 211
683 DIALYSIS 210
684 FAILURE TO THRIVE 209
685 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 209
686 HYPERPYREXIA 208
687 TENDERNESS 208
688 STATUS EPILEPTICUS 207
689 PROTHROMBIN TIME PROLONGED 206
690 VAGINAL HAEMORRHAGE 206
691 ASTHMA 205
692 CORONARY ARTERY DISEASE 205
693 BONE MARROW DISORDER 204
694 OLIGURIA 204
695 PRODUCT DOSE OMISSION IN ERROR 204
696 LUNG CONSOLIDATION 203
697 ANASTOMOTIC LEAK 202
698 BONE LESION 202
699 CARDIOMEGALY 202
700 CONGESTIVE CARDIOMYOPATHY 202
701 PERIPHERAL MOTOR NEUROPATHY 202
702 CLOSTRIDIAL INFECTION 201
703 INJURY 201
704 WOUND INFECTION 201
705 ANAL ABSCESS 200
706 TOXIC ENCEPHALOPATHY 200
707 GASTRIC PERFORATION 199
708 LUNG NEOPLASM 199
709 GASTROINTESTINAL INFECTION 198
710 INJECTION SITE REACTION 197
711 BASAL CELL CARCINOMA 196
712 CEREBRAL ISCHAEMIA 196
713 CYANOSIS 196
714 HIP FRACTURE 196
715 RESPIRATORY ARREST 196
716 SOFT TISSUE INFECTION 196
717 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 196
718 VARICES OESOPHAGEAL 196
719 VENTRICULAR HYPOKINESIA 196
720 CHOLECYSTITIS ACUTE 195
721 GENE MUTATION 195
722 PORTAL VEIN THROMBOSIS 195
723 OSTEOARTHRITIS 194
724 PAIN OF SKIN 194
725 RADIATION SKIN INJURY 194
726 BLOOD LACTIC ACID INCREASED 193
727 MIGRAINE 193
728 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 192
729 TOOTH DISORDER 192
730 ASPIRATION 191
731 DISTURBANCE IN ATTENTION 191
732 HEAD INJURY 191
733 KLEBSIELLA SEPSIS 191
734 SCAB 191
735 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 190
736 INJECTION SITE ERYTHEMA 190
737 NEUTROPENIC INFECTION 190
738 CARDIAC TAMPONADE 189
739 EXPOSURE DURING PREGNANCY 189
740 HYPERNATRAEMIA 189
741 STENOTROPHOMONAS INFECTION 188
742 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 187
743 FEMUR FRACTURE 187
744 PHARYNGITIS 187
745 WOUND DEHISCENCE 187
746 BLOOD POTASSIUM INCREASED 186
747 CARDIOVASCULAR DISORDER 186
748 ERYTHEMA MULTIFORME 186
749 IMMUNE SYSTEM DISORDER 186
750 OSTEOPOROSIS 186
751 UROSEPSIS 186
752 DYSSTASIA 185
753 AGEUSIA 184
754 DERMATITIS BULLOUS 184
755 HISTIOCYTOSIS HAEMATOPHAGIC 184
756 THERAPY CHANGE 184
757 APHTHOUS ULCER 183
758 BK VIRUS INFECTION 183
759 INTRACRANIAL PRESSURE INCREASED 183
760 RECTAL CANCER 183
761 ABDOMINAL ABSCESS 182
762 FOLLICULITIS 182
763 DYSAESTHESIA 181
764 HYPOAESTHESIA ORAL 181
765 PRODUCT PRESCRIBING ISSUE 181
766 GASTRIC HAEMORRHAGE 180
767 HYPERLIPIDAEMIA 180
768 HYPERSOMNIA 180
769 MYCOBACTERIUM CHELONAE INFECTION 180
770 RESPIRATORY SYNCYTIAL VIRUS INFECTION 180
771 STREPTOCOCCAL SEPSIS 180
772 CHEILITIS 179
773 EAR PAIN 179
774 MYELODYSPLASTIC SYNDROME TRANSFORMATION 179
775 PHOTOSENSITIVITY REACTION 179
776 BLOOD URINE PRESENT 178
777 HYPOFIBRINOGENAEMIA 178
778 LIMB DISCOMFORT 178
779 METASTASES TO PLEURA 178
780 GASTRIC DISORDER 177
781 LOWER GASTROINTESTINAL HAEMORRHAGE 177
782 OCULAR HYPERAEMIA 177
783 URINE OUTPUT DECREASED 177
784 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 177
785 FULL BLOOD COUNT ABNORMAL 176
786 IMMUNE THROMBOCYTOPENIA 176
787 JUGULAR VEIN THROMBOSIS 176
788 VASCULITIS 176
789 FUSARIUM INFECTION 175
790 ONYCHOCLASIS 175
791 DRUG EFFECT INCOMPLETE 174
792 TOOTH ABSCESS 174
793 ISCHAEMIA 173
794 PARAESTHESIA ORAL 173
795 PERIPHERAL ISCHAEMIA 173
796 RETINAL HAEMORRHAGE 173
797 ARTHROPATHY 172
798 BODY TEMPERATURE DECREASED 172
799 NASAL CONGESTION 172
800 IRRITABILITY 171
801 STREPTOCOCCAL BACTERAEMIA 171
802 SYSTEMIC MYCOSIS 171
803 TRICUSPID VALVE INCOMPETENCE 171
804 EYE SWELLING 170
805 JAUNDICE CHOLESTATIC 170
806 ABASIA 169
807 ADENOCARCINOMA 169
808 COMPUTERISED TOMOGRAM ABNORMAL 169
809 FACIAL PARALYSIS 169
810 HYPOACUSIS 169
811 LUNG NEOPLASM MALIGNANT 169
812 TUMOUR HAEMORRHAGE 169
813 ATRIAL FLUTTER 168
814 HYPERURICAEMIA 168
815 RASH PAPULAR 168
816 SENSORY LOSS 168
817 INCONTINENCE 167
818 RENAL INJURY 167
819 VENTRICULAR EXTRASYSTOLES 166
820 CANDIDIASIS 165
821 ENDOCARDITIS 165
822 METABOLIC DISORDER 165
823 PARALYSIS 165
824 CHRONIC MYELOID LEUKAEMIA 164
825 DIFFUSE ALVEOLAR DAMAGE 164
826 MOVEMENT DISORDER 164
827 MULTIPLE-DRUG RESISTANCE 163
828 PLATELET TRANSFUSION 163
829 PULMONARY THROMBOSIS 163
830 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 162
831 EYE DISORDER 162
832 FLANK PAIN 162
833 MUSCLE TWITCHING 162
834 ONYCHOMADESIS 162
835 SQUAMOUS CELL CARCINOMA 162
836 NEUROLOGICAL SYMPTOM 161
837 PANCREATIC CARCINOMA METASTATIC 161
838 PHLEBITIS 161
839 PHOTOPHOBIA 161
840 CATHETER SITE INFECTION 160
841 ECCHYMOSIS 160
842 RASH GENERALISED 160
843 SPINAL PAIN 160
844 CAECITIS 159
845 EXTRAVASATION 159
846 HEPATITIS B REACTIVATION 159
847 ORAL INTAKE REDUCED 159
848 SKIN IRRITATION 159
849 SQUAMOUS CELL CARCINOMA OF SKIN 159
850 STRIDOR 159
851 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 158
852 RESPIRATORY RATE INCREASED 158
853 APPLICATION SITE ERYTHEMA 157
854 DIFFERENTIATION SYNDROME 157
855 DYSKINESIA 157
856 ELECTROCARDIOGRAM ABNORMAL 157
857 EMBOLISM VENOUS 157
858 RALES 155
859 DERMATITIS ALLERGIC 154
860 SKIN NECROSIS 154
861 STREPTOCOCCAL INFECTION 154
862 ABDOMINAL TENDERNESS 153
863 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 153
864 ONYCHOLYSIS 153
865 PYELONEPHRITIS 153
866 SERUM FERRITIN INCREASED 153
867 VENA CAVA THROMBOSIS 153
868 ANAL INCONTINENCE 152
869 ENTEROCOCCAL BACTERAEMIA 152
870 GINGIVAL PAIN 152
871 MENTAL DISORDER 152
872 ARTERIOSCLEROSIS CORONARY ARTERY 151
873 CARDIAC DYSFUNCTION 151
874 DRUG LEVEL INCREASED 151
875 HEMIPLEGIA 151
876 THYMUS HYPOPLASIA 151
877 COLD SWEAT 150
878 MANTLE CELL LYMPHOMA 150
879 NODULE 149
880 PNEUMONIA KLEBSIELLA 149
881 FAECALOMA 148
882 GRAND MAL CONVULSION 148
883 LEFT VENTRICULAR FAILURE 148
884 LYMPHOID TISSUE HYPOPLASIA 148
885 RIB FRACTURE 148
886 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 147
887 DEVICE RELATED THROMBOSIS 147
888 SINUS BRADYCARDIA 147
889 SMALL INTESTINAL PERFORATION 147
890 DEVICE OCCLUSION 146
891 LARYNGEAL OEDEMA 146
892 PROTEIN TOTAL DECREASED 146
893 EYELID PTOSIS 145
894 FRACTURE 145
895 TOXIC LEUKOENCEPHALOPATHY 145
896 RED CELL DISTRIBUTION WIDTH INCREASED 144
897 TYPE 2 DIABETES MELLITUS 144
898 IMPAIRED QUALITY OF LIFE 143
899 OESOPHAGEAL STENOSIS 143
900 PARAPLEGIA 143
901 SUBCLAVIAN VEIN THROMBOSIS 143
902 ANAL FISTULA 142
903 BLOOD CHOLESTEROL INCREASED 142
904 HAIR COLOUR CHANGES 142
905 PATHOLOGICAL FRACTURE 142
906 PRODUCT ADMINISTRATION ERROR 142
907 SKIN CANCER 142
908 DRUG EFFECT DECREASED 141
909 INTERVERTEBRAL DISC PROTRUSION 141
910 INVASIVE DUCTAL BREAST CARCINOMA 141
911 MYELOFIBROSIS 141
912 TORSADE DE POINTES 141
913 APPLICATION SITE PAIN 140
914 CENTRAL NERVOUS SYSTEM LYMPHOMA 140
915 PELVIC PAIN 140
916 PULSE ABSENT 140
917 TUMOUR PERFORATION 140
918 VIRAEMIA 140
919 ABDOMINAL INFECTION 139
920 FLUID INTAKE REDUCED 139
921 MOTOR DYSFUNCTION 139
922 THROMBOPHLEBITIS 139
923 CARDIOPULMONARY FAILURE 138
924 BLOOD URIC ACID INCREASED 137
925 DECUBITUS ULCER 137
926 FEBRILE INFECTION 137
927 MENINGITIS 137
928 BLOOD CREATININE DECREASED 136
929 PAPILLOEDEMA 136
930 PLASMA CELL MYELOMA 136
931 SPINAL OSTEOARTHRITIS 136
932 SUSPECTED OFF LABEL USE 136
933 BLOOD PRESSURE SYSTOLIC INCREASED 135
934 EMOTIONAL DISORDER 135
935 HUMAN BOCAVIRUS INFECTION 135
936 LOCAL SWELLING 135
937 MUSCULOSKELETAL DISORDER 135
938 CLOSTRIDIUM TEST POSITIVE 134
939 ESCHERICHIA URINARY TRACT INFECTION 134
940 LUNG OPACITY 134
941 OESOPHAGEAL CARCINOMA 134
942 ANAL FISSURE 133
943 BONE MARROW TOXICITY 133
944 HEPATIC NEOPLASM 133
945 HYPOTHERMIA 133
946 NON-HODGKIN^S LYMPHOMA 133
947 MADAROSIS 132
948 NON-CIRRHOTIC PORTAL HYPERTENSION 132
949 PREMATURE DELIVERY 132
950 ROAD TRAFFIC ACCIDENT 132
951 CHRONIC MYELOMONOCYTIC LEUKAEMIA 131
952 GINGIVITIS 131
953 LARGE INTESTINAL OBSTRUCTION 131
954 SKIN HAEMORRHAGE 131
955 STEROID DIABETES 131
956 TUBERCULOSIS 131
957 GOUT 130
958 HAIR TEXTURE ABNORMAL 130
959 ORAL DISCOMFORT 130
960 SARS-COV-2 TEST POSITIVE 130
961 TOOTH INFECTION 130
962 ASPERGILLOSIS 129
963 BLOOD CREATINE INCREASED 129
964 CANCER PAIN 129
965 CEREBELLAR SYNDROME 129
966 OSTEOPENIA 129
967 PHARYNGEAL INFLAMMATION 129
968 PRODUCT QUALITY ISSUE 129
969 PSEUDOMONAL BACTERAEMIA 129
970 PULMONARY ARTERIAL HYPERTENSION 129
971 PULMONARY CONGESTION 129
972 TRISMUS 129
973 ACCIDENTAL OVERDOSE 128
974 BLOOD TRIGLYCERIDES INCREASED 128
975 DENTAL CARIES 128
976 EMPHYSEMA 128
977 GLOSSODYNIA 128
978 HEART RATE IRREGULAR 128
979 HYDROCEPHALUS 128
980 INTENTIONAL PRODUCT MISUSE 128
981 LYMPHANGIOSIS CARCINOMATOSA 128
982 MANTLE CELL LYMPHOMA RECURRENT 128
983 NEUROLOGICAL DECOMPENSATION 128
984 VENTRICULAR DYSFUNCTION 128
985 ANGIOPATHY 127
986 DEMENTIA 127
987 HEPATOSPLENOMEGALY 127
988 PIK3CA-ACTIVATED MUTATION 127
989 ACUTE LEUKAEMIA 126
990 BLOOD GLUCOSE DECREASED 126
991 BREAST PAIN 126
992 HEPATIC CYST 126
993 IRON DEFICIENCY ANAEMIA 126
994 STOMA SITE HAEMORRHAGE 126
995 ARTERIOSCLEROSIS 125
996 ERUCTATION 125
997 THROMBOCYTOSIS 125
998 AMYLASE INCREASED 124
999 BRAIN ABSCESS 124